The thesis of this essay is that Jesus Christ, the absolutely supreme Creator, Sustainer, and Ruler of the universe, intends to accomplish his saving purposes in the world without reliance on the powers of civil government to teach, defend, or spread the Christian religion as such. Followers of Christ should not use the sword of…
Audio Transcript Welcome back to the podcast. This week we’re looking at controversy. We opened the week looking at the sick love of controversy. In APJ 1949, on Monday, we looked at this disease called “craving for controversy,” as Paul calls it in 1 Timothy 6:4. Today we look at how to best speak of…
Date and Time June 28–29, 20231:00–5:00 p.m. ET Overview This meeting brings together researchers, pharmacists and other pharmacy-involved professionals, community members, and federal partners to discuss research opportunities in how pharmacies are used to provide HIV testing, prevention, and care. Pharmacies are often seen as places where people can go for health care without feeling judged…
A study funded by Avadel Pharmaceuticals, which just launched Lumryz for narcolepsy in the US, describes clinician preferences among oxybate treatments for narcolepsy and highlights a need for once-at-bedtime oxybate dosing. Among 100 clinicians, the primary driver of overall oxybate choice, potential to improve patient quality of life, and decrease stress/anxiety was a single bedtime…
Sleep-disordered breathing is more prevalent among short-snouted dogs than those with longer snouts, according to University of Helsinki researchers who tested a new method of diagnosing sleep-disordered breathing in dogs by using a neckband developed for human sleep apnea diagnostics. The study was published in the Journal of Veterinary Internal Medicine. French bulldogs, pugs, and…
June 14, 2023 • Research Highlight People who experience adversity during childhood are often at greater risk of developing mental illnesses in adulthood. A recent study led by Matthew Birnie, Ph.D., of the University of California, Irvine, and colleagues, sheds light on how negative early life experiences may impact how we act in response to…
A clinical trial will investigate the integration of neurodiagnostic company Beacon Biosignals’ at-home electroencephalogram (EEG) into digital biomarkers company Koneksa’s Neuroscience Solution Toolkit to discover biomarkers and determine the usability and validity of measures of sleep and neurologic disorders collected using at-home EEG, wearables, and smartphones. The Koneksa-sponsored clinical validation study, “A basket observational study…